Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
/in International Publications, Newcastle Disease Virus /von 2016-04-20 / Oncolytic Virother 2016;5:27-34Novel immunotherapeutic approaches to the treatment of urothelial carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-02-09 / Ther Adv Urol 2016 Jun;8(3):203-14Viro-immune therapy: A new strategy for treatment of pancreatic cancer
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-63Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2016-01-06 / Viruses 2016 Jan;8(1)Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
/in International Publications, Malignant Lymphoma, Newcastle Disease Virus /von 2015-12-23 / Viruses 2015 Dec;8(1)Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
/in International Publications, Newcastle Disease Virus /von 2015-12-21 / J. Exp. Clin. Cancer Res. 2015 Dec;34:153Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-12-16 / Mol. Cancer 2015 Dec;14:210Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy
/in International Publications, Newcastle Disease Virus, NSCLC /von 2015-11-15 / Am J Cancer Res 2015;5(12):3612-23Oncolysis by paramyxoviruses: preclinical and clinical studies
/in International Publications, Newcastle Disease Virus /von 2015-10-21 / Mol Ther Oncolytics 2015;2
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de